Biogen (BIIB) Minority Interest (2009 - 2023)

Biogen's Minority Interest history runs 15 years deep, the most recent figure standing at -$4.1 million for Q3 2023.

• In Q3 2023, Minority Interest rose 52.87% year-over-year to -$4.1 million; the TTM figure through Sep 2023 stood at -$4.1 million (up 52.87% YoY), while the FY2022 annual figure was -$9.5 million, down 114.96% from the prior year.
• Minority Interest for Q3 2023 stood at -$4.1 million, up from -$6.4 million in the prior quarter.
• The five-year high for Minority Interest was $462.9 million in Q2 2021, with the low at -$21.6 million in Q1 2022.
• The 5-year median for Minority Interest is -$8.7 million (2022), against an average of $42.8 million.
• The sharpest annual moves came in 2020 and 2021: Minority Interest slumped 375.61% in 2020, then soared 3327.14% in 2021.
• Biogen's Minority Interest stood at -$4.1 million in 2019, then sank by 246.34% to -$14.2 million in 2020, then soared by 547.18% to $63.5 million in 2021, then slumped by 114.96% to -$9.5 million in 2022, then jumped by 56.84% to -$4.1 million in 2023.
• Business Quant data shows BIIB's Minority Interest at -$4.1 million in Q3 2023, -$6.4 million in Q2 2023, and -$9.6 million in Q1 2023.